Progress in Dermatology and Venereology in 2023 as Reflected in the Journal of the European Academy of Dermatology and Venereology
December 2023
in “
JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
Studysummary This study found that among melanoma patients in a real-world setting, adjuvant anti-PD-1 antibodies and BRAF/MEK inhibitors were associated with a recurrence-free survival of 78.1% and 86.5% respectively after 12 months.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer